Document:

Exhibit 10.56

 

Wonderland Capital Corp

200 East Broadway

Port Jefferson, NY 11772

 

 

 

 

As of March 25, 2011                         

 

Viral Genetics, Inc.

2290 Huntington Drive, Suite 100 San

Marino, CA 91108

 

Attn: Mr. Haig Keledjian

          President

 

Dear Mr. Keledjian:

 

This letter agreement (this "Agreement")
shall confirm the understanding and agreement between Wonderland Capital Corp. (the "Lender"), and Viral Genetics, Inc.,
(the "Company"), with respect to the Loan (as hereinafter defined) from the Lender to the Company.

 

That understanding and agreement in as follows:

 

1.     The Lender will loan $100,000 to Viral in two tranches, the first in the amount of $50,000 to be made today and the second tranche
in the amount of $50,000 to be made approximately 10 to 14 days from this date. The proceeds of the Loan shall pay all costs necessary
to fund a "fast-track" test by the Company's subsidiary, VGE Energy, Inc. ("VGE"), and the remainder shall
be used by the Company for general corporate purposes.

 

2.  The Loan will be evidenced by a convertible promissory note made jointly and severally by the Company and VGE (the "Note"),
shall mature and be payable six (6) months after the date of issuance (the "Maturity Date") and shall earn interest on
the outstanding principal amount of the Note at a rate of 2% per annum (calculated on the basis of a year of 360 days). The Note
shall not be prepayable.

 

3. In consideration of making the Loan, the Company shall immediately
issue to the Lender 500 000of the Company's Series A Preferred Stock and an option ("Option") to purchase
ten (10) VGE Units (as hereinafter defined). The Option shall be exercisable for a period of six (6) months from its date of issuance.

 

4. The Note, shall be convertible prior
to the Maturity Date, at the sole option of the Lender, upon two (2) business days prior written notice to the Company, into shares
of the Company's common stock at a conversion price of $0.02 per share (the "Conversion Price"). Notwithstanding anything
set forth in the immediately preceding sentence, the Conversion Price shall be lowered to the lowest price per share at which the
Company issues common stock (including, without limitation, by means of the conversion of any security of the issuance of shares
under any warrant) as long as this Note is outstanding. The Conversion Price shall be subject to customary anti-dilution protection.

 

    	 

    	 

    

 

5. For purposes hereof each "VGE Unit"
shall be defined and comprised of the following:

 

(a) one hundred fifty thousand (150,
000) shares of common stock of VGE;

 

(b) fifteen thousand (15,000) shares of Series A Preferred Stock of VGE; and

 

(c)  five (5) year warrants to acquire one hundred fifty thousand (50,000) shares of common stock of VGE at an exercise price of $0.25
per share (the "VGE Warrants"). The Option exercise price for each VGE Units shall be $25,000. The exercise price of
the VGE Warrants will be subject to customary anti-dilution protection.

 

6. Promptly after the execution and delivery
of this letter Agreement, the Lender, the Company and VGE, as applicable, will enter into a Securities Purchase Agreement, the
Note and any other applicable documentation to memorialize the transaction contemplated by this Agreement and the Loan (the "Definitive
Documentation") and shall take all corporate actions to implement the transaction contemplated by the Agreement and the Loan.

 

7. Each party hereby represents and warrants to the other parties
that:

 

(a) it has the full
power, ability, legal capacity and authority to execute and deliver the Agreement and to perform its obligations hereunder;
and

 

(b) this Agreement
constitutes its legal, valid and binding obligation, enforceable against it in accordance with its term, except
as enforceability may be limited by applicable bankruptcy, moratorium, insolvency and other similar laws affecting the
enforcement of creditors' rights generally and that enforcement may be limited by general principles of equity.

 

8. Until the Definitive Documentation is
executed and delivered, this Agreement sets forth the entire understanding and agreement of the parties with respect to the Loan
and the transactions contemplated hereby and the subject matter hereof and its supersedes all prior understandings and/or contemporaneous
agreements (if any) between them (whether written of oral) with respect to such matter, all of which are merged herein.

 

9. This Agreement may not be amended, modified,
waived or terminate, except by an instrument in writing executed by each of the parties hereto. Any waiver of any provision of
this Agreement shall be limited to the specific instance and purpose for which it is given.

 

10. This Agreement shall not be assigned
by any party without the prior written consent of the other party and their respective successors and permitted assignees.

 

11. This Agreement shall be governed by
and construed in accordance with the laws of the State of New York, without regard to any of its conflicts of law principles which
would result in the application of the laws of another jurisdiction.

 

    	 

    	 

    

 

12. The Agreement
may be executed in counterparts (and they may be executed by facsimile or electric signature which shall be valid for
purposes hereof) each of which shall be an original, and all of which, when taken together, shall constitute over and the
same agreement. In resolving any dispute or controversy arising out of this Agreement or construing any term or provision in
this Agreement, there shall be no presumption made or inference drawn because of the inclusion of a provision not contained
in a prior draft or deletion of a provision contained in a prior draft. This Agreement shall not be construed or interpreted
with any presumption against either party and for purposes of construing and interpreting this Agreement, it shall be deemed
that this Agreement was drafted jointly by the parties. Any reference in this Agreement to the masculine, feminine or neuter
gender shall be a reference to such other gender as if appropriate. References in this Agreement to the singular shall
include the plural and vice versa.

 

Please confirm the Company and VGE's agreement
to this Agreement by executing and returning the enclosed copy of this Agreement to the Lender.

 

 

	 	Very truly yours,

    

    Wonderful Capital Corp.

    Lender

    

    By: /s/ Eugene W. Austin

           Name: Eugene W. Austin

           Title: President

 

 

Agreed and Accepted:

 

VIRAL GENETICS, INC.

 

 

By: Haig Keledjian

Name: Haig Keledjian

Title: President

 

VG ENERGY, INC.

 

 

By: Haij Keledjian

Name: Haij Keledjian

Title: PresidentExhibit 10.57

 

RELEASE AND SETTLEMENT

 

Dated this 1st day of April 2011, by and between Viral Genetics,
Inc., a Delaware corporation ("Viral") and DMBM, Inc., a New York corporation ("DMBM").

 

WHEREAS DMBM has agreed to purchase a 5% Unsecured Convertible Debenture
issued December 3, 2009 in the principal amount of $116,108.19 (the "Note") from the University License Equity Holding
Inc. under an Assignment Agreement dated March 1, 2011 (the "Assignment"); and

 

WHEREAS payment of the Purchase Price (as defined in the Assignment)
for the Note is in Payment Tranches (as defined in the Assignment), and DMBM and Viral are mutually desirous of irrevocably establishing
the terms of settling and releasing the Note in advance but which shall take effect upon completion of each Payment. Tranche.

 

NOW THEREFORE for good and lawful consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties agree as follows.

 

1. Upon payment of each Payment Tranche, DMBM hereby:

 

a. represents and warrants that it will have full right, title
and ownership to the Note Tranche described in the Assignment under Section 2;

 

b. irrevocably tenders and assigns to Viral full right, ownership
and title to the each Note Tranche in exchange for shares of common stock of Viral at the price of $0.01 per share for an aggregate
of twelve million, three hundred seventy six thousand, five hundred and sixty (12,376,560) shares of common stock of Viral for
the entire Note, including shares issuable for accrued interest; and

 

c. provides a complete and irrevocable release of any and all liabilities,
fees, penalties, interests or claims of any kind in regard to each Note Tranche so purchased and the amounts owed pursuant thereto,
and acknowledges that, upon tender of the final Note Tranche, the Note in its entirety shall be and is satisfied in full.

 

2.This agreement shall be governed by the laws of the State
of California.

 

3.If any of the Payment Tranches is not completed on the timeline
specified in the Assignment Agreement, only those Note Tranches that have been so paid for shall be tendered, released and settled
hereunder and otherwise this Agreement shall terminate.Exhibit 10.58

 

THIS AMENDING AGREEMENT is made effective as
of the 1st day of June, 2011,

 

BETWEEN:

 

VIRAL GENETICS INC.

a Delaware incorporated company

(hereinafter referred to as “Viral”)

 

OF THE FIRST PART

 

and

 

VG ENERGY INC.

a Delaware incorporated company

(hereinafter referred to as “VG”)

 

OF THE SECOND PART

 

and

 

METACYTOLYTICS, INC.

a Delaware incorporated company

(hereinafter referred to as “Meta”)

 

OF THE THIRD PART

 

and

 

PATTON CAPITAL CORP.

an Alberta incorporated
company

(hereinafter referred to as “Patton”)

 

OF THE FOURTH PART.

 

WHEREAS pursuant to an agreement dated
the 5th day of August, 2010 (hereinafter referred to as the “Original Consultant Fee Agreement” attached hereto as Schedule
“A”), made between Viral and Patton, certain activities and payments were contracted and the parameters were determined
for the remuneration of Patton acting as a consultant;

 

AND WHEREAS Viral provided a letter of amendment
dated October 28, 2010, (“Letter of Amendment” attached hereto as Schedule “B”) which incorporated VG
and Meta to be an original party to the Original Consultant Fee Agreement;

 

    	1

    	 

    

 

AND WHEREAS Viral, VG, Meta and Patton
all agree to extend the Original Consultant Fee Agreement, as amended, for another eighteen (18) months from the date of natural
termination.

 

NOW THEREFORE THIS AMENDING AGREEMENT WITNESSETH
that in consideration of the mutual obligations and agreements herein contained, the parties hereto covenant and agree to
the provisions of this Amending Agreement as follows:

 

Article

AMENDMENTS

 

1.1 Amendments to Original Consultant Fee Agreement

 

Effective June 1, 2011, the Original Consultant Fee Agreement shall
be amended as follows:

 

	(a)		The first line in Section 4.1:

 

"This Agreement shall have a Term of 12 months from the date
affixed hereof, and may be extend thereafter by mutual written consent."

 

shall be substituted therefore with the following:

 

"This Agreement shall have a Term of thirty (30) months from
the date affixed hereof, and may be extend thereafter by mutual written consent."

 

	(b)		The signatories to the Original Consultant Fee Agreement attached as Schedule "A"
hereto shall be expanded by adding the parties VG and Meta to the Original Consultant Fee Agreement as if they had originally
been a signatory thereto from the initial date of execution.

 

	(c)		The Letter of Amendment attached as Schedule "B" to this Amending Agreement
shall be affirmed, acknowledged and accepted by all parties as being in full force and effect and further affirms that the Original
Consultant Fee Agreement has been so amended by the October 28, 2010 Letter of Amendment. The signatories to the Letter of Amendment
shall be expanded by adding the parties VG, Meta and Patton to the Letter of Amendment as if they had originally been a signatory
thereto from the initial date of execution.

 

1.2  Effective Date

 

The Effective Date of this Amending Agreement is as of the date
first -written above.

 

Article

DECLARATORY AND INTERPRETATIVE
PROVISIONS

 

2.1 Definitions

  

    	2

    	 

    

 

2.2 Interpretation

 

This Amending Agreement is declared to be supplemental
to the Original Consultant Fee Agreement and the Letter of Amendment and is to form part of and shall have the same effect as though
incorporated in the Original Consultant Fee Agreement and the Letter of Amendment.

 

The Original Consultant
Fee Agreement and the Letter of Amendment is a part of these presents and is, by this reference, included herein with the same
effect as though set forth at length herein and, except as amended hereby, the terms of the Original Consultant Fee Agreement and
Letter of Amendment are hereby ratified and confirmed without alteration or amendment.

 

2.3 Original Consultant Fee Agreement and Letter of Amendment

 

Reference in this Amending Agreement to the
Original Consultant Fee Agreement and Letter of Amendment shall, wherever the context requires it, mean the Original Consultant
Fee Agreement and Letter of Amendment as supplemented and amended from time to time and for the time being.

 

2.4 Governing Law

 

This Amending Agreement shall be governed by
and construed in accordance with the laws of the Province of Alberta and all parties hereby irrevocably attorn to the jurisdiction
and courts of Alberta.

 

Article

COUNTERPART EXECUTION

 

3.1 Execution in Counterpart

 

This Amending Agreement may be executed in
any number of counterparts by the parties to it on separate counterparts, each of which shall be deemed an original and all of
which together shall constitute one and the same agreement.

 

IN
WITNESS WHEREOF the parties hereto have executed this Amending Agreement under their respective corporate seals and the hands
of their proper officers this 27th day of  June 2011, with effect as of the date first above written.

 

	 	VIRAL GENETICS INC.
	 	 
	 	per /s/ Haig Keledjian
	 	Haig Keledjian
		President

 

 

    	3

    	 

    

 

	 	VG ENERGY INC.
	 	 
	 	per /s/ Haig Keledjian
	 	Haig Keledjian
		President

 

 

	 	METACYTOLYTICS, INC.
	 	 
	 	per /s/ Haig Keledjian
	 	Haig Keledjian
		President

 

 

	 	PATTON CAPITAL CORP.
	 	 
	 	per  _______________________
	 	
		per _______________________

 

 

    	4

    	 

    

 

SCHEDULE “A”

 

CONSULTANT FEE AGREEMENT

 

 

 

THIS CONSULTANT FEE AGREEMENT (“Agreement”)
dated the 5th day of August, 2010.

 

Between:

 

VIRAL GENETICS INC.,

a Delaware incorporated company

(the “Company”)

 

-and-

 

PATTON CAPITAL CORP.

(the “Consultant”)

 

 

WHEREAS the Company wishes to appoint the Consultant
to introduce the Company to prospective Consultant Introductions (as defined below) on a non-exclusive basis as to one or more
Transactions (as defined below) and on an exclusive basis as to the Listing (as defined below), and the Consultant wishes to accept
such appointment;

 

NOW THEREFORE FOR GOOD AND VALUABLE CONSIDERATION,
the parties agree as follows:

 

1. Appointment and Acceptance

 

	1.1		The Company hereby appoints the Consultant to make
                                                                               Consultant Introductions for the purpose of securing a Transaction or Listing, and the Consultant hereby accepts such
                                                                               appointment (it being understood that, in acting as a consultant, the Consultant may introduce the Company to persons who may
                                                                               in turn introduce the Company to other persons (all such introductions, whether directly by Consultant or through entities
                                                                               introduced by Consultant, as well as Consultant itself and it's officers, directors and principal shareholders, are
                                                                               hereinafter referred to as “Consultant Introductions”)) in consideration of the compensation to which the
                                                                               Consultant is entitled under the terms of this Agreement. A "Listing" shall result where, through Consultant
                                                                               Introductions, the Company secures, acquires or merges with a NASDAQ listed company and/or obtains any other suitable listing
                                                                               on a recognized stock exchange, including the Toronto Stock Exchange, including a merger, reverse merger,reverse takeover
                                                                               and/or an acquisition transaction. A "Transaction" shall result where, through Consultant Introductions the Company
                                                                               secures or obtains any business development opportunity or cash funding, including, without limiting the generality of the
                                                                               foregoing,
license arrangements, research funding including government and non government grants, partnerships, joint
ventures, and public or private financings whether by way of debt or equity or a combination of both (two or more activities shall
be referred to as “Transactions”). A Listing resulting from a reverse takeover, reverse merger, acquisition or other
corporate reorganization or combination with a NASDAQ- or other recognized exchange-listed company, including the Toronto Stock
Exchange, holding cash, where, following closing, the shareholders of the Company before the Listing own more than 50% of the surviving
entity after closing, /or more than 50% of the board of directors of the surviving entity following closing were directors of the
Company before closing shall result in fees payable for a Transaction as defined in section 3.3. The acceptance and closing of
any part or all of any Transactions or Listing or combination thereof shall be at the sole discretion of the Company.

 

    	5

    	 

    

 

	1.2		The Company hereby acknowledges that the Consultant is not a registered broker, dealer
or an investment adviser within the meaning of the Canadian or United States securities laws or any provincial or state securities
laws.

 

2.Information

 

	2.1		The Company will furnish the Consultant with all required information of the Company
including a copy of the business plan prepared by the Company along with all ancillary required information (the “Business
Plan”) and in that connection will provide the Consultant reasonable and full access to the Company's officers, directors,
outside advisors, attorneys, auditors, accountants and other representatives or parties dealing with the Company. The Company
will be solely responsible for all such information including the contents of the Business Plan or other documents used in connection
with the consulting activities contemplated hereby. To the best of the Company's knowledge, after making all due inquiry and diligence,
all information to be furnished by the Company will be true and correct in all material respects. The Company agrees to the terms
of indemnification attached in Schedule A.

 

3.Compensation

 

	3.1		The Consultant shall be paid a fee of $8,000 on signing hereof and $8,000 on the 181
day of every month thereafter (“Monthly Fee”). The Monthly Fee is non-refundable and may be paid by way of shares or
cash as mutually agreed to by the parties. Where the payment is by way of shares, the price for each share shall be the lower
of $0.041 (the "Maximum Price") or the closing market price of the Company's common shares on the day that the Monthly
Fee is due, or if not a trading day then the following trading day. The Maximum Price shall subject to adjustment according to
section 3.5 below.

 

    	6

    	 

    

 

	3.2		In addition to the payments made by the Company to the Consultant in section 3.1 above,
upon the first and only the first closing (“Closing”) of all or part of any Transaction or the Listing, whether or not
the Company issues equity or equity equivalents, the Company will issue to the Consultant eleven million (11,000,000) warrants
to purchase shares of the Company (the “Warrants”) under the following terms and conditions. The exercise price of all
Warrants will be equal to the lower of the Maximum Price or the closing price of the Company's common shares on the date of the
Closing. The number of Warrants issuable shall be subject to adjustment according to section 3.5 herein. All Warrants to be issued
to the Consultant are exercisable for five (5) years from the date of issue and shall survive any reorganizations or restructurings,
and will be subject to registration rights that are equivalent to the most favourable rights then in place or granted subsequently
by the Company to other investors or shareholders for warrants or other stock options, as determined in the sole discretion of
the Consultant.

 

	3.3		In addition to the compensation contained in sections 3.1 and 3.2 above, where the
Company secures a Transaction, the Consultant shall be paid an amount equal to ten percent (10%) of the value of such Transaction
in cash plus an additional ten percent (10%) of the value of such Transaction in shares of the Company at a price equal to the
price per share for the funding or financing as the case may be, or, if no such price is available, then the then current market
price of the Company's common shares determined as the closing price on the date of the Closing.

 

	3.4		In addition, the Company shall be required to reimburse the Consultant for all out-of-pocket
expenses incurred and disbursements paid by the Consultant in the course of performing its duties under the terms of this Agreement;
provided, however, that the Consultant shall obtain the Company's prior written consent to such reimbursement over the amount
of one thousand dollars ($1,000.00), which consent shall not be unreasonably withheld.

 

	3.5		In the event that the Company shall undertake a recapitalization, reverse stock split,
forward stock split, reclassification, or other change to its common stock (a “Change in Common Stock Properties”),
the quantity of Warrants and the Maximum Price shall be increased or decreased proportionately, in accordance with the terms of
said Change in Common Stock Properties. ·

 

	3.6		In consideration of the Consultant providing its services to the Company under the
terms and conditions set forth in this Agreement, the parties hereto expressly agree that the Consultant shall be entitled to
compensation hereunder in connection with the activities provided for in this Agreement under sections 3.2 and 3.3 with respect
to all or part of a Transaction or Listing, financial or otherwise, entered into by the Company during
the term of this Agreement and for a period of twenty-four (24) months following termination of this Agreement and the Consultant
shall be remunerated accordingly as if this Agreement was still in full force and effect.

 

    	7

    	 

    

 

4.Term and Termination

 

	4.1		This Agreement shall have a Term of 12 months from the date affixed hereof, and may
be extended thereafter by mutual written consent. This Agreement may be terminated any time, however, with or without cause, by
either the Company or the Consultant. Termination of this Agreement shall not relieve the Company of its obligation to compensate
the Consultant pursuant to Section 3.6 of this Agreement. If this Agreement is terminated prior to the end of the initial 12-month
Term for any reason, the Monthly Fees shall continue to be due and payable to the Consultant for the initial 12-month Term. If
terminated at any time thereafter, only the Monthly Fees owed up to and including the date of termination shall be due and payable.

 

5.Securities Laws

 

The Consultant acknowledges that:

 

	5.1		No securities commission or similar regulatory authority has reviewed or passed on
the merits of the securities;

 

	5.2		There is no government or other insurance covering the securities;

 

	5.3		There are risks associated with the purchase of the securities; and

 

	5.4		The Company has advised the Consultant that the Company is relying on an exemption
from the requirements to provide a prospectus or any other form of disclosure documentation and to sell securities through a person
or company registered to sell securities under the Securities Act (Alberta) and, as a consequence of acquiring securities
pursuant to this exemption, certain protections, rights and remedies provided by the Securities Act (Alberta), including
statutory rights of rescission or damages, will not be available to the subscriber nor the Consultant.

 

	5.5		They are a Non-US Person.

 

6.Further Assurances

 

	6.1		The parties agree to take all necessary actions and execute such additional documentation
as may be necessary in order to implement this Agreement.

 

7.Amendments and Waivers

 

    	8

    	 

    

 

	7.1		Any term of this Agreement may be amended, waived or superseded only by mutual written
consent of the Company and/or its legal representatives and the Consultant or their respective permitted successors and assigns.
Any amendment or waiver effected in accordance with this Section shall be binding upon the parties and their respective permitted
successors and assigns.

 

8.Successors and Assigns

 

	8.1		Either party shall have the right to assign its rights, obligations and privileges
(by operation of law or otherwise) hereunder to an assignee that agrees in writing to be bound by the terms and conditions of
this Agreement with the consent of the other party, such consent not to be unreasonably withheld. Company hereby acknowledges
and consents to Consultant assigning any or all of the compensation due to Consultant hereunder provided that such assignment
is permitted under applicable securities laws. The terms and conditions of
the Agreement shall enure to the benefit of and be binding upon the respective permitted successors and assigns of the parties.
Nothing in the Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective
successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly
provided in this Agreement.

 

9.Governing law

 

	9.1		The Agreement and all acts and transactions pursuant to this Agreement and the rights
and obligations of the parties hereto shall irrevocably be governed, construed and interpreted in accordance with the laws of
the Province of Alberta, without giving effect to principles of conflicts of law.

 

10.Jurisdiction

 

	10.1		Each of the parties to this Agreement irrevocably attorn to the exclusive jurisdiction
and venue of the provincial and federal courts of the Province of Alberta.

 

11.Titles and Subtitles

 

	11.1		The titles and subtitles used in this Agreement are used for convenience only and
are not to be considered in construing or interpreting this Agreement.

 

12.Notices

 

	12.1		Any notice required or permitted by this Agreement shall be in writing and shall be
deemed sufficient, when delivered by courier, overnight delivery service or confirmed facsimile, or forty-eight (4 hours after
being deposited in the regular mail as certified or registered mail (airmail if sent internationally) with postage prepaid, if
such notice is addressed to the party to be notified at such party's address or facsimile number as set forth below, or as subsequently
modified by written notice.

 

    	9

    	 

    

 

13. Severability

 

	13.1		If one or more provisions of this Agreement are held to be unenforceable under applicable
law, the parties agree to renegotiate such provision in good faith, in order to maintain the economic position enjoyed by each
party as close as possible to that under the provision rendered unenforceable.In the event that the parties cannot reach a
mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement,
(ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement
shall be enforceable in accordance with its terms.

 

14.Independent Contractor

 

	14.1		Neither party shall, for any purpose, be deemed to be an agent of the other party
and the relationship between the parties shall only be that of independent contractors. Neither party shall have any right or
authority to assume or create any obligations or to make any representations or warranties on behalf of any other party, whether
express or implied, or to bind the other party in any respect whatsoever (other than by the terms and provisions of this Agreement).

 

15.Confidentiality

 

	15.1		The Consultant agrees to keep confidential and not to disclose any information designated
as confidential by the Company to any third parties other than to a list approved by the Company of its officers, directors, employees,
representatives or agents. This confidentiality obligation shall survive termination of this agreement in perpetuity. This confidentiality
obligation shall not apply to Information for which the Consultant can demonstrate that such information (i) has been approved
for release by written authorization of the Company; (ii) is or becomes part of information in the public domain through no fault
of the Consultant; (iii) was known by the Consultant prior to the disclosure thereof by the Company; or (iv) properly comes into
the possession of the Consultant from a third party which is not under any obligation to maintain the confidentiality of such
information.

 

16.Entire Agreement

 

    	10

    	 

    

 

	16.1		This Agreement constitutes the entire agreement of the parties pertaining to the subject
matter hereof, and merges all prior negotiations and drafts of the parties with regard to the transactions contemplated herein.
Any and all other written or oral agreements existing between the parties hereto regarding such transactions are expressly cancelled.

 

17.Advice of Legal Counsel

 

	17.1		Each party acknowledges and represents that, in executing the Agreement, it has had
the opportunity to seek advice as to its legal rights from legal counsel and that the person signing on its behalf has read and
understood all of the terms and provisions of this Agreement. This Agreement shall not be construed against any party by reason
of the drafting or preparation thereof.

 

18.Arbitration

 

	18.1		Any controversy or claim arising out of or relating to this Agreement or the performance
or breach thereof shall be settled by arbitration in the, or such other venue as the parties agree, in accordance with the rules
and procedures of the Arbitration Act of Alberta. If more than one past or present agent or finder of the Company, including the
Consultant, claims to have introduced the same opportunity, the determination of the allocation of commissions will be settled
by arbitration.

 

19.Counterparts

 

	19.1		This Agreement may be signed in separate counterparts (including by telecopy), each
of which will be deemed an original and both of which together will constitute one and the same agreement.

 

    	11

    	 

    

 

 

 

    	12

    	 

    

 

Schedule
A: Indemnity

 

 

 

 

The Company
(the "Indemnifying Party''} hereby agrees to indemnify and hold the Consultant and each and every of the directors, officers,
employees, shareholders, agents and representatives of the Consultant (hereinafter referred to as the "Personnel") harmless
from and against any and all expenses, losses, claims, actions, obligations, damages or liabilities, whether joint or several (including
the aggregate amount paid in reasonable settlement of any actions, suits, proceedings or claims), and the reasonable fees and expenses
of its counsel that may be incurred in advising with respect to or defending any claim that may be made against the Consultant
or its Personnel to which the Consultant or its Personnel may become subject or otherwise involved in any capacity insofar as such
expenses, losses, claims, damages, liabilities or actions arise out of or are based, directly or indirectly, upon the engagement
of the Consultant hereunder or the performance of professional services rendered to the Indemnifying Party by the Consultant and
its Personnel hereunder or otherwise in connection with the matters referred to in the attached letter agreement, provided, however,
that this indemnity shall not apply to the extent that a court of competent jurisdiction in a final judgment that has become non-appealable
shall determine that:

 

i) the Consultant
or its Personnel have been grossly negligent or dishonest or have committed any fraudulent act in the course of such performance;
and

 

ii) the
expenses, losses, claims, actions, obligations, damages or liabilities, as to which indemnification is claimed, were directly caused
by the gross negligence, dishonesty or fraud referred to in (i).

 

If
for any reason (other than the occurrence of any of the events itemized in (i) and (ii)
above), the foregoing indemnification is unavailable to the Consultant or its Personnel or is insufficient
to hold it harmless, then the Indemnifying Party shall contribute to the amount paid or payable by the Consultant or its Personnel
as a result of such expense, loss, claim, actions, damage or liability in such proportion as is appropriate to reflect not only
the relative benefits received by the Indemnifying Party on the one hand and the Consultant on the other hand but also the relative
fault of the Indemnifying Party and the Consultant, as well as any relevant equitable considerations; provided that the Indemnifying
Party shall in any event contribute to the amount paid or payable by the Consultant as a result of such expense, loss, claim, actions,
damage or liability any excess of such amount over the amount of the fees received by the Consultant hereunder pursuant to this
Agreement.

 

The Indemnifying
Party agrees that in case any legal proceeding shall be brought against the Indemnifying Party, the Consultant or its Personnel
by any governmental commission or regulatory authority or any stock exchange or other entity having regulatory authority, either
domestic or foreign, shall investigate the Indemnifying Party or the Consultant and any Personnel of the Consultant shall be required
to testify in connection therewith or shall be required to respond to procedures designed to discover information regarding, in connection with, or by reason of the performance of professional services rendered
to the Indemnifying Party by the Consultant, the Consultant or its Personnel shall have the right to employ its own counsel in
connection therewith, and the reasonable fees and expenses of such counsel as well as the reasonable costs (including an amount
to reimburse the Consultant for time spent by its Personnel in connection therewith) and out-of-pocket expenses incurred by its
Personnel in connection therewith shall be paid by the Indemnifying Party as they occur.

 

Promptly after receipt of notice of the commencement
of any legal proceeding against the Consultant or any of its Personnel or after receipt of notice of the commencement of any investigation,
which is based, directly or indirectly, upon any matter in respect of which indemnification may be sought from the Indemnifying
Party, the Consultant will notify the Indemnifying Party in writing of the commencement thereof and, throughout the course thereof,
will provide copies of all relevant documentation to the Indemnifying Party, will keep the Indemnifying Party advised of the progress
thereof and will discuss with the Indemnifying Party all significant actions proposed.

 

The indemnity and contribution obligations of the Indemnifying Party shall be in addition to any liability
which the Indemnifying Party may otherwise have, shall extend upon the same terms and conditions to the Personnel of the Consultant
and shall be binding upon and enure to the benefit of any successors, assigns, heirs and personal representatives of the Indemnifying
Party, the Consultant and any of the Personnel of the Consultant. The foregoing provisions shall survive the completion of professional
services rendered under this Agreement or any termination of the authorization given by the Agreement.

 

 

	 	VIRAL GENETICS INC.
	 	 
	 	Per: /s/ Haig Keledjian

 

 

 

    	13

    	 

    

 

 

SCHEDULE “B”

 

Letter of Amendment
Dated October 28, 2010

 

 

V I R A L G E N E T I C S

2290 Huntington
Drive, Suite 100, San Marino, CA, 91108, Tel: (626) 334-5310, Fax: (626) 334-5324 

 

October 28, 2010

 

Pat MacDonald

Patton Capital Corp.

3604 — 7A St. SW.

Calgary,
AB

 

	RE:		Consultant Fee Agreement between Viral Genetics, Inc., a Delaware corporation ("Company")
and Patton Capital Corp., an Alberta corporation ("Consultant") dated August 5, 2010 (the "Agreement")

 

Dear Sir:

 

As further clarification and confirmation of certain fund-raising
services provided by Consultant, this letter will confirm that Consultant's origination of financing for any subsidiary of the
Company, including, without limitation, financing for VG Energy Inc., a Delaware corporation, or MetaCytoLytics, Inc., a Delaware
corporation, shall upon closing constitute a "Transaction" under Section 1.1 of the Agreement and result in compensation
payable to Consultant by Company as further described therein.

 

Additionally, the Company hereby agrees that any such compensation
payable to Consultant under Section 33 in connection with a Transaction of the type described in the paragraph above may be deemed
payable in cash, shares of common stock of the Company, securities of such subsidiary, or any, combination thereof, as mutually
agreed to by Company and Consultant prior to closing of such Transaction.

 

VIRAL GENETICS, INC.

 

/s/ Haig Keledjian

Haig
Keledjian, President

626-334-5310

haig@viralgenetics.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]